Cell‐free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer

Cell‐free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer

The emergence of targeted therapies has transformed ovarian cancer treatment. However, biomarker profiling for precision medicine is limited by access to quality, tumour‐enriched tissue samples. The use of cell‐free DNA (cfDNA) in ascites presents a potential solution to this challenge. In this stud...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bonnita Werner, Elyse Powell, Jennifer Duggan, Marilisa Cortesi, Yeh Chen Lee, Vivek Arora, Ramanand Athavale, Michael Dean, Kristina Warton, Caroline E. Ford
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Molecular Oncology
Subjects:	ascites biomarkers cell‐free DNA homologous recombination deficiency ovarian cancer precision medicine
Online Access:	https://doi.org/10.1002/1878-0261.13710
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic effects of cyclophosphamide, dsDNA preparations and combinations thereof against Krebs-2 ascites cancer cells and various cancer transplants
by: E. A. Potter, et al.
Published: (2016-03-01)

Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01)

Non-Cirrhotic Ascites: Causes and Management
by: Paul Carrier, et al.
Published: (2024-10-01)

Analysis of different therapeutic schemes combining cyclophosphamide and doublestranded DNA preparation for eradication of Krebs-2 primary ascites in mice
by: E. A. Potter, et al.
Published: (2016-03-01)

Eradication of Krebs-2 primary ascites via a single-injection regimen of cyclophosphamide and double-stranded DNA
by: E. A. Potter, et al.
Published: (2016-12-01)

Rapid in vitro method to assemble and transfer DNA fragments into the JCVI-syn3B minimal synthetic bacterial genome through Cre/loxP system
by: Atsuko Uenoyama, et al.
Published: (2024-12-01)

Development of the therapeutic regimen based on the synergistic activity of cyclophosphamide and double-stranded DNA preparation which results in complete cure of mice engrafted with Krebs-2 ascites
by: E. A. Potter, et al.
Published: (2016-12-01)

Saccharomyces cerevisiae Rev7 promotes non-homologous end-joining by blocking Mre11 nuclease and Rad50’s ATPase activities and homologous recombination
by: Sugith Badugu, et al.
Published: (2024-12-01)

A Rare Case of Deep Pelvic Endometriosis Presenting with Serous Ascites and Infertility
by: Türkan Gürsu, et al.
Published: (2015-08-01)

Ascites of unknown origin in infant: a rare case report
by: Rendi Aji Prihaningtyas, et al.
Published: (2024-09-01)

Case report and literature review of refractory hypoalbuminemic ascites caused by so-dium valproate
by: Hui-Min YANG, et al.
Published: (2021-10-01)

Multidisciplinary management of chylous ascites following resection of a retroperitoneal, functional Paraganglioma
by: Edouard H. Nicaise, et al.
Published: (2024-11-01)

Research progress and treatment status of malignant ascites
by: Jing He, et al.
Published: (2024-12-01)

Fetal Ovarian Cyst Rupture Resulting in Transient Fetal Ascites
by: Ömer Kandemir, et al.
Published: (2014-08-01)

Intraperitoneal Steroid Therapy for Recurrent Malignant Ascites in Advanced Cancer Patients: A Case Series
by: Nashid Islam, et al.
Published: (2025-01-01)

Isolated Fetal Ascite Associated with Cardiac Diseases
by: Vehbi Doğan, et al.
Published: (2014-12-01)

Spontaneous bladder rupture masquerading as loculated ascites with septations in postpartum – A case report
by: Saunri Hansadah, et al.
Published: (2024-11-01)

Effect of barley processing and enzyme supplementation on broiler performance, gut morphometry, and the occurrence of ascites syndrome in broiler chickens
by: Mina Zohrabi, et al.
Published: (2024-12-01)

Competence induction of homologous recombination genes protects pneumococcal cells from genotoxic stress
by: David De Lemos, et al.
Published: (2025-01-01)

Postoperative chylous ascites successfully managed by selective lymphatic embolization: Case report and literature review
by: Nguyen Ngoc Cuong, PhD, et al.
Published: (2025-02-01)

Parameters of the Component Composition of the Body and Their Relationship with the Development of Ascites in Liver Cirrhosis
by: Yu. O. Zharikov, et al.
Published: (2024-08-01)

Real-world experience with long-term albumin in patients with cirrhosis and ascites
by: Enrico Pompili, et al.
Published: (2024-12-01)

A rare presentation of Sjogren\'s syndrome with ascites and liver fibrosis in a young woman: a Case report
by: Mohammad Reza Farzaneh Far, et al.
Published: (2024-08-01)

Utility of flow cytometry ascitic fluid analysis for rapid diagnosis of B-cell peritoneal lymphomatosis
by: Maria Laura Bisegna, et al.
Published: (2022-08-01)

Evaluation of Ascitic Fluid Cytology in a Tertiary Hospital in South-Western Nigeria: A 7-year Retrospective Study
by: Oluwatosin O. Oguntoye, et al.
Published: (2024-11-01)

PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition
by: Sookhee Pae, et al.
Published: (2024-12-01)

Gestational exposure to arsenic reduces female offspring fertility by impairing the repair of DNA double-strand breaks and synapsis formation in oocytes
by: Cong Ma, et al.
Published: (2025-01-01)

Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)

Detailed analysis of the histology-specific impact of ascites volume on the outcome of epithelial ovarian cancer: a multi-institutional retrospective cohort study
by: Shohei Iyoshi, et al.
Published: (2024-11-01)

Improving Growth Performance, Biochemical Parameters and Reducing Mortality due to Ascites in Broilers by Propranolol Inclusion
by: Shahriar Saidian, et al.
Published: (2024-12-01)

Variables associated with antibiotic administration for performing paracentesis among patients with ascites in a community hospital
by: Nikisha Pandya, et al.
Published: (2024-03-01)

The Role of Correcting Structural and Functional Albumin Properties in Ascites Control in Decompensated Cirrhotic Patients
by: A. A. Turkina, et al.
Published: (2023-09-01)

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
by: Yinan Xiao, et al.
Published: (2025-01-01)

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma
by: Ahmed Bilal Khalid, et al.
Published: (2024-11-01)

A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
by: Xingxing Li, et al.
Published: (2025-01-01)

Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons
by: Yuan Gao, et al.
Published: (2024-11-01)

Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
by: Tianqi Luo, et al.
Published: (2025-01-01)

De novo assembly of the mitochondrial genome of Glycyrrhiza glabra and identification of two types of homologous recombination configurations caused by repeat sequences
by: Guowang Zhou, et al.
Published: (2025-01-01)

CRISPR-Cas9-mediated enhancement of Beauveria bassiana virulence with overproduction of oosporein
by: Gabriel Moura Mascarin, et al.
Published: (2024-11-01)

Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations
by: Ahao Wu, et al.
Published: (2024-08-01)